INDIA has transformed itself into a global health leader in terms of affordability, innovation, and inclusivity over the past decade.
India’s pharmaceutical industry is a global giant ranking third in volume and 14th in value.
It’s the largest supplier of generic medicines providing 20 per cent of the world’s supply and a key player in affordable vaccines.
In 2023-24, the sector’s turnover hit Rs 4,17,345 crore growing steadily at over 10 per cent annually for the past five years.
For the common people, this means more medicines at lower prices, better healthcare and jobs in factories and labs across the country. From small towns to big cities, India’s pharma growth is creating opportunities and saving lives.
The government claims that its schemes are the backbone of this success.
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) runs 15,479 Jan Aushadhi Kendras, offering generic medicines at prices up to 80 per cent lower than branded ones.
ANI
#GlobalNewLightOfMyanmar